Reuters logo
BRIEF-Race Oncology executes LOI with TargImmune Therapeutics AG
July 10, 2017 / 1:21 AM / in 3 months

BRIEF-Race Oncology executes LOI with TargImmune Therapeutics AG

July 10 (Reuters) - Race Oncology Ltd

* Race joint venture with targimmune-rac.ax

* Executed a letter of intent with Targimmune Therapeutics to enter into a joint venture

* JV will focus on developing new and improved cancer therapies based on combining bisantrene with Targimmune’s targeted cancer therapy technology Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below